CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
15 févr. 2022 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
Dental Care Medical Ceramics Market to Grow at a CAGR of Nearly 6% by 2031: Comprehensive Research by Fact.MR
15 févr. 2022 15h30 HE
|
FACT.MR
ROCKVILLE, Md., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rise in application in various medical fields such as dental implants, bone implants, and kidney dialysis machines and equipment has been fuelling...
Positive Results for Lipid inCode® in NHS Clinical Study
15 févr. 2022 02h00 HE
|
GENinCode Plc
OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion...
Radcliffe Group Launches New Branding to Signal the Start of a Year of Innovation and Investment
10 févr. 2022 10h09 HE
|
Radcliffe Group Ltd
LONDON, England, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Radcliffe Group has unveiled a new brand identity across its core business, including its three specialist channels: Radcliffe Cardiology,...
Global Cardiovascular Needle and Prosthetic Devices Market Trend of 2022 with Insights Research Report, Share By Type, Size By End User, Exploring Sales Volume Revenue, Comprehensive Growth And Forecast 2027
10 févr. 2022 08h42 HE
|
360 Market Updates
Pune, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Part 1 : Global Cardiovascular Needle Market The report provides in-depth analysis and insights into the current global market scenario, latest trends,...
CVRx to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 15, 2022
01 févr. 2022 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
FDA Pre-Submission Filed for Cardio inCode-SCORE
11 janv. 2022 02h30 HE
|
GENinCode Plc
OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its...
Prolocor to Participate at Biotech Showcase 2022
10 janv. 2022 09h00 HE
|
Prolocor Inc
PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prolocor Inc, a healthcare startup developing an innovative precision diagnostic test that quantifies FcγRIIa on the surface of platelets, today...
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
10 janv. 2022 08h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year
22 déc. 2021 16h05 HE
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LR With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol)...